FOLLOW THE EVIDENCE
Cannabis research,
clearly mapped.
A sober guide to what scientists know, what the law says, and where uncertainty remains.
Evidence has a shape.
We help you see it.
THC is one molecule.
“Cannabis” is not one intervention.
Product composition, route, exposure, population, and outcome all change what a study can tell us. Our evidence pages preserve those distinctions.
START HERE
The questions people ask most
What is THC? A research-first guide
How delta-9-tetrahydrocannabinol interacts with the body, what researchers measure, and where simple explanations fall short.
What is CBD? Claims, evidence, and approved medicine
CBD is not simply non-intoxicating THC. Its pharmacology, evidence, interactions, and regulation require their own explanation.
THCA vs. THC: chemistry before marketing
The acidic precursor and its decarboxylated product are related, but labels and legal shorthand often obscure the chemistry.
LAW & POLICY
One plant.
Hundreds of rulebooks.
Compare the legal frameworks that shape access, research, medicine, and enforcement. Every profile links to an official authority and carries a review date.
Open the law atlas →EVIDENCE DESK
Read past the headline
Cannabinoid hyperemesis syndrome: signs and evidence
A recurrent vomiting syndrome associated with prolonged cannabis exposure—and why recognition matters.
Cannabis side effects and risk factors
A structured overview of short-term effects, longer-term associations, and groups that face higher risk.
Epidiolex: what an approved CBD medicine proves
The indications, evidence, controls, and monitoring behind the first FDA-approved purified cannabidiol drug.
OUR STANDARD
Curious enough to ask.
Careful enough to qualify.
Primary sources first.
We link readers to the paper, regulator, statute, or trial record behind the claim.
Uncertainty stays visible.
Study design, conflicts, limitations, and contradictory findings belong in the story.
No sales agenda.
We do not sell products, rank dispensaries, or publish consumption and cultivation guides.